Skip to main content
Clinical Trials/NL-OMON22704
NL-OMON22704
Recruiting
Not Applicable

Ong-term onCologicAL outcomes of endoscopic full-thickness resection after previous incomplete resection of low-risk T1 CRC

Amsterdam University Medical Center, location AMC0 sites153 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
endoscopic full thickness resectioncolorectal polypT1 colorectal cancercolonoscopy
Sponsor
Amsterdam University Medical Center, location AMC
Enrollment
153
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Amsterdam University Medical Center, location AMC

Eligibility Criteria

Inclusion Criteria

  • Patients meeting all of the following criteria will be invited for participation in the study:
  • \-Recent polypectomy/(p)EMR/ESD of T1 CRC without the following histological high\-risk features\*:
  • oPoor differentiation
  • oLymphovascular invasion (NB if lymphovascular invasion cannot be assessed, patients are NOT eligible for inclusion)
  • oTumor budding grade 2/3 (NB if tumor budding cannot be assessed at histopathology, patients are NOT eligible for inclusion)
  • \-This recent polypectomy/(p)EMR/ESD for T1 CRC resulted in positive resection margins \< 0\.1mm (R1\) or indeterminate resection margins (Rx)
  • \-The resection scar after polypectomy/EMR/ESD is clearly recognized at endoscopy, either by a tattoo or by detecting a scar in the colonic segment where no other polypectomies were performed
  • \-The diameter of the original lesion was \= 30 mm
  • \-The diameter of the scar and/or residual lesion \= 15 mm
  • \-The interval between index polypectomy/EMR and additional eFTR is at most 12 weeks

Exclusion Criteria

  • Patients meeting any of the following criteria will be excluded from participation in this study:
  • \-If lymphovascular invasion and/or tumor budding grade 2/3 cannot be assessed after prior polypectomy/(p)EMR, patients are NOT eligible for inclusion
  • \-The patient is known with at least one of the following conditions:
  • oActive inflammatory bowel disease (IBD) in the colon
  • oSynchronous advanced CRC (defined as CRC in the 5 years before detection of T1 CRC, or elsewhere in the colorectum at the time of detection of T1 CRC)
  • \-Index lesion located \< 5 cm of the anal verge or with involvement of the valvula Bauhini or appendiceal orifice
  • \-Age \< 18 years
  • \-Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Clinical Outcome and Complications of Full Endoscopic Interlaminar Lumbar Discectomyumbar Disc HerniationSciaticaLumbar RadiculopathyFull&#45endoscopic Interlaminar Lumbar DisectomyPercutaneous discectomySciaticaLumbar Radiculopathy
TCTR20171002001/A480
Completed
Not Applicable
Short and long term outcomes of the endoscopic submucosal dissection for the colorectal tumors: single center, large, cohort studyColorectal neoplasms
JPRN-UMIN000021023Tomoaki Tashima1,000
Recruiting
Not Applicable
Outcomes for patients undergoing endoscopic therapy for Barrett’s related neoplasia: over 10-year experience from the Dutch Barrett Expert CentersBarrett's esophagusBarrett's related neoplasia
NL-OMON29089ead site:Academic Medical Center Amsterdam (AMC)Collaborating centers:•Sint Antonius Hospital Nieuwegein•Catharina Hospital, Eindhoven•University Medical Center, Utrecht•Isala Clinics, Zwolle•Erasmus Medical Center, Rotterdam•Haga Hospital, Den Haag•University Medical Center, Groningen2,000
Completed
Not Applicable
The study of long-term prognosis after endoscopic submucosal dissection for early gastric cancer in elderly patients with frailtyearly gastric cancer
JPRN-UMIN000035483Yokohama City University School of Medicine Department of Gastroenterology and Hepatology100
Completed
Not Applicable
Retrospective Analysis of outcome after endoscopic therapy of symptomatic esophago-gastrointestinal stenoses in Patients with Crohn's disease at the Robert-Bosch-Krankenhaus Stuttgart between January 2008 and May 2018K50.0K52.3Crohn disease of small intestineIndeterminate colitis
DRKS00015906Robert Bosch Medizinische Forschung (RBMF) des Robert Bosch Krankenhaus Stuttgart163